| |
Products Home |
|
|
| |
Manufacturing Facility: MeiRui¡¯s GMP manufacturing facility is located in the Nanjing Economic and Technology Development Zone on a 40,000 M2 parcel. The main manufacturing building is 4,300 M2, with a 2,000 M2 warehouse and a 700 M2 attached auxiliary building. The facility makes all the Company¡¯s pharmaceutical products. The facility makes solid and liquid-filled capsules and specialty cosmetic creams and gels. The plant currently operates at about 10% of its maximum capacity. |
|
|
| |
Urology Products |
|
|
| |
Products: MeiRui¡¯s leading product is Prostat, its proprietary drug for the treatment of benign prostatic hyperplasia and prostatitis. MeiRui also produces, Sheniting (Tolterodine) indicated for the treatment of an overactive bladder. Additional pharmaceutical products include; Naftopidil, a treatment of bladder outlet obstruction; Finasteride, indicated for the treatment of BPH and Cetirizine, an antihistamine indicated for the relief of allergy and hay fever. |
|
|
| |
Diagnostic Products |
|
|
| |
MeiRui markets immunodiagnostic equipment and supplies its trading company Nanjing WeiKangLe Co., Ltd. (WKL).WKL markets the ImmunoCAP equipment and reagents manufactured by Phadia, the parent company of Allergon AB. The ImmunoCAP system is the leader in the field of allergen antibody detection and quantitation, it is the world¡¯s only complete and comprehensive allergy diagnostic system. |
|
|
| |
Product Pipeline |
|
|
| |
MeiRui has a number of products in its development pipeline. The company is concentrating on therapeutics used in urology and is expanding its product line into therapeutics used in geriatric practice. |
|
|
|
|
